Citigroup Inc Inmune Bio, Inc. Transaction History

Citigroup Inc

$163 Billion
Q4 2024

A detailed history of Citigroup Inc transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Citigroup Inc holds 10,831 shares of INMB stock, worth $89,464. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,831

Previous 9,757 11.01%

Holding current value

$89,464

Previous $52,000 3.85%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$4.4 - $6.43 $4,725 - $6,905	1,074 Added 11.01%	10,831 $50,000
Q3 2024 Nov 12, 2024	BUY	$4.86 - $9.86 $34,510 - $70,015	7,101 Added 267.36%	9,757 $52,000
Q2 2024 Aug 12, 2024	SELL	$7.15 - $11.84 $324,524 - $537,393	-45,388 Reduced 94.47%	2,656 $23,000
Q1 2024 May 10, 2024	BUY	$10.53 - $14.01 $127,876 - $170,137	12,144 Added 33.83%	48,044 $564,000
Q4 2023 Feb 09, 2024	BUY	$6.6 - $11.52 $236,940 - $413,568	35,900 New	35,900 $404,000
Q2 2022 Aug 10, 2022	BUY	$5.48 - $8.97 $7,124 - $11,661	1,300 New	1,300 $11,000

Others Institutions Holding INMB

# of Institutions

Shares Held

7.07M

Call Options Held

202K

Put Options Held

42.9K

View Full List

About Inmune Bio, Inc.

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $148M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

More about INMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account